Skip to main content

Advertisement

Log in

LEOPARD syndrome with recurrent PTPN11 mutation Y279C and different cutaneous manifestations: two case reports and a review of the literature

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

LEOPARD syndrome (LS) is a heterogeneous disease characterised mainly by cutaneous manifestations. LEOPARD is the acronym for its major features—multiple lentigines, electrocardiographic conduction defects, ocular hypertelorism, pulmonary stenosis, abnormalities of (male) genitalia, retardation of growth and sensorineural deafness. As clinical manifestations are variable, molecular testing is supportive in the diagnosis of LS. We describe two unrelated LS cases with a common PTPN11 mutation Y279C and with completely different clinical features including distinct changes in skin pigmentation. In patient 1, the first complaint was hyperactive behaviour. First lentigines were presented at birth, but intensive growth began at the age of 2–4 years. Multiple dark lentigines were located mainly on the face and the upper part of the trunk, but the oral mucosa was spared. Patient 2 was born from induced labour due to polyhydramnion, and in the second week of life, mitral valve insufficiency and hypertrophic cardiomyopathy were diagnosed. Rapid growth of lentigines began at the age of 3 years. These are mostly located in the joint areas in the lower extremities; the face and upper trunk are spared from lentigines. In both cases, the rapid growth of lentigines made it possible to shift the diagnosis towards LS. Clinicians should give more consideration to rare genetic syndromes, especially in the case of symptoms from different clinical areas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

SHP-2:

src homology-2 (SH2)-containing protein tyrosine phosphatase (PTP)

PTPN11:

Protein-tyrosine phosphatase, non-receptor type 11

References

  1. Adriaenssens T, Ibrahim T, Seyfarth M (2007) The LEOPARD syndrome: a rare condition associated with hypertrophic cardiomyopathy. Eur Heart J 28(24):3066

    Article  PubMed  Google Scholar 

  2. Conti E, Dottorini T, Sarkozy A, Tiller GE, Esposito G, Pizzuti A, Dallapiccola B (2003) A novel PTPN11 mutation in LEOPARD syndrome. Hum Mutat 21:654

    Article  CAS  PubMed  Google Scholar 

  3. Digilio MC, Conti E, Sarkozy A, Mingarelli R, Dottorini T, Marino B, Pizzuti A, Dallapiccola B (2002) Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene. Am J Hum Genet 71:389–394

    Article  CAS  PubMed  Google Scholar 

  4. Digilio MC, Sarkozy A, Pacileo G, Limongelli G, Marino B, Dallapiccola B (2006) PTPN11 gene mutations: linking the Gln510Glu mutation to the “LEOPARD syndrome phenotype”. Eur J Pediatr 165:803–805

    Article  CAS  PubMed  Google Scholar 

  5. Digilio MC, Sarkozy A, de Zorzi A, Pacileo G, Limongelli G, Mingarelli R, Calabrò R, Marino B, Dallapiccola B (2006) LEOPARD syndrome: clinical diagnosis in the first year of life. Am J Med Genet 140A:740–746

    Article  Google Scholar 

  6. Gorlin RJ, Anderson RC, Blaw M (1969) Multiple lentigines syndrome. Am J Dis Child 17:652–662

    Google Scholar 

  7. Keren B, Hadchouel A, Saba S, Sznajer Y, Bonneau D, Leheup B, Boute O, Gaillard D, Lacombe D, Layet V, Marlin S, Mortier G, Toutain A, Beylot C, Baumann C, Verloes A, Cavé H (2004) PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience. J Med Genet 41:e117. doi:10.1136/jmg.2004.021451

    Article  CAS  PubMed  Google Scholar 

  8. Koudova M, Seemanova E, Zenker M (2009) Novel BRAF mutation in a patient with LEOPARD syndrome and normal intelligence. Eur J Med Genet 52:337–340. doi:10.1016/j.ejmg.2009.04.006

    Article  PubMed  Google Scholar 

  9. Legius E, Schrander-Stumpel C, Schollen E, Pulles-Heintzberger C, Gewillig M, Fryns J-P (2002) PTPN11 mutations in LEOPARD syndrome. J Med Genet 39:571–574

    Article  CAS  PubMed  Google Scholar 

  10. Limongelli G, Pacileo G, Marino B, Digilio MC, Sarkozy A, Elliott P, Versacci P, Calabro P, De Zorzi A, Di Salvo G, Syrris P, Patton M, McKenna WJ, Dallapiccola B, Calabro R (2007) Prevalence and clinical significance of cardiovascular abnormalities in patients with the LEOPARD syndrome. Am J Cardiol 100:736–741

    Article  PubMed  Google Scholar 

  11. Limongelli G, Sarkozy A, Pacileo G, Calabrò P, Digilio MC, Maddaloni V, Gagliardi G, Di Salvo G, Iacomino M, Marino B, Dallapiccola B, Calabrò R (2008) Genotype–phenotype analysis and natural history of left ventricular hypertrophy in LEOPARD syndrome. Am J Med Genet Part A 146A:620–628

    Article  PubMed  Google Scholar 

  12. Pandit B, Sarkozy A, Pennacchio LA, Carta C, Oishi K, Martinelli S, Pogna EA, Schackwitz W, Ustaszewska A, Landstrom A, Bos JM, Ommen SR, Esposito G, Lepri F, Faul C, Mundel P, Siguero JPL, Tenconi R, Selicorni A, Rossi C, Mazzanti L, Torrente I, Marino B, Digilio MC, Zampino G, Ackerman MJ, Dallapiccola B, Tartaglia M, Gelb BD (2007) Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy. Nat Genet 39(8):1007–1012

    Article  CAS  PubMed  Google Scholar 

  13. Sarkozy A, Conti E, Digilio CM, Marino B, Morini E, Pacileo G, Wilson M, Calabrò R, Pizzuti A, Dallapiccola B (2004) Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome. J Med Genet 41:e68. doi:10.1136/jmg.2003.013466

    Article  CAS  PubMed  Google Scholar 

  14. Sarkozy A, Digilio MC, Dallapiccola B (2008) Leopard syndrome. Orphanet J Rare Dis 3:13

    Article  PubMed  Google Scholar 

  15. Sarkozy A, Carta C, Moretti S, Zampino G, Digilio MC, Pantaleoni F, Scioletti AP, Esposito G, Cordeddu V, Lepri F, Petrangeli V, Dentici ML, Mancini GMS, Selicorni A, Rossi C, Mazzanti L, Marino B, Ferrero GB, Silengo MC, Memo L, Stanzial F, Faravelli F, Stuppia L, Puxeddu E, Gelb BD, Dallapiccola B, Tartaglia M (2009) Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: molecular diversity and associated phenotypic spectrum. Hum Mutat 30:695–702

    Article  CAS  PubMed  Google Scholar 

  16. Tartaglia M, Mehler E, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD (2001) Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet 29:465–468

    Article  CAS  PubMed  Google Scholar 

  17. Yoshida R, Nagai T, Hasegawa T, Kinoshita E, Tanaka T, Ogata T (2004) Two novel and one recurrent PTPN11 mutations in LEOPARD syndrome. Am J Med Genet 130A:432–434

    Article  PubMed  Google Scholar 

  18. Wu R, Legius E, Robberecht W, Dumoulin M, Cassiman JJ, Fryns JP (1996) Neurofibromatosis type I gene mutation in a patient with features of LEOPARD syndrome. Hum Mutat 8:51–56

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors are grateful to the patients and their families for their participation. This study was supported by grants from the Estonian Science Foundation GARMP 6573, GARLA 6808 and by target financing grant SF 0180096s08.

Conflict of interest statement

The authors declare no competing financial interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ingrid Kalev.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kalev, I., Muru, K., Teek, R. et al. LEOPARD syndrome with recurrent PTPN11 mutation Y279C and different cutaneous manifestations: two case reports and a review of the literature. Eur J Pediatr 169, 469–473 (2010). https://doi.org/10.1007/s00431-009-1058-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-009-1058-1

Keywords

Navigation